- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06146361
Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19
April 3, 2025 updated by: Maria Eugenia Fernandez-Esquer, The University of Texas Health Science Center, Houston
Vale+ Tu Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19.
The purpose of this study is to assess the extent to which LDL report increased adherence with COVID 19 mitigation practices 1 month post intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
359
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Self-identify as Hispanic or Latino
- Be present at the corner for the purposes of looking for work
Exclusion Criteria:
- Have not been previously hired to work at a corner
- Symptoms of COVID-19 in the previous 48 hours
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard of Care
|
This group will receive a COVID-19 prevention flyer and social resources list only
|
|
Experimental: COVID-19 Group Problem Solving
|
This group will have three core components to be delivered at the corner by trained data collectors.
Interactive dialogue component that incorporates popular education activities aimed at developing social cohesion among LDLs, building awareness about COVID-19 risks and protective behaviors and developing a plan of action to reduce their and their peers' risk for COVID-19 transmission.
Navigation Component will consist of providing information and linking LDLs with social service providers that can help buffer some of the social and economic effects of the COVID-19 pandemic and the "Multiplicador de salud"/Health Multiplier component that builds from the theoretical and practice-based method of mobilizing social networks and social support, defined as encouraging social networks to provide informational, emotional, appraisal, and instrumental support as cited in the Taxonomy of Behavior Change Methods.
This group will receive a COVID-19 prevention flyer and social resources list only
|
|
Experimental: Group Problem Solving Plus Booster Session
|
This group will have three core components to be delivered at the corner by trained data collectors.
Interactive dialogue component that incorporates popular education activities aimed at developing social cohesion among LDLs, building awareness about COVID-19 risks and protective behaviors and developing a plan of action to reduce their and their peers' risk for COVID-19 transmission.
Navigation Component will consist of providing information and linking LDLs with social service providers that can help buffer some of the social and economic effects of the COVID-19 pandemic and the "Multiplicador de salud"/Health Multiplier component that builds from the theoretical and practice-based method of mobilizing social networks and social support, defined as encouraging social networks to provide informational, emotional, appraisal, and instrumental support as cited in the Taxonomy of Behavior Change Methods.
This group will receive a COVID-19 prevention flyer and social resources list only
Participants will have a 10 - 15 minute "booster' session about a week after engaging in the small group intervention.
They will be contacted by phone and the booster will consist of brief prompts to engage participants in a discussion to encourage them to act on their personal commitments to protect themselves and others against COVID.
They will also be encouraged to seek COVID related resources based on the information provided during the small group intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Compliant With COVID Vaccination Guidelines as Assessed by a Survey
Time Frame: Baseline
|
Measure of compliance with COVID vaccination guidelines.
|
Baseline
|
|
Number of Participants Compliant With COVID Vaccination Guidelines as Assessed by a Survey
Time Frame: 4 weeks post intervention
|
Post test measure of compliance with COVID vaccination guidelines.
|
4 weeks post intervention
|
|
Mask Wearing Frequency as Assessed by a Survey
Time Frame: Baseline
|
Mask Wearing frequency is reported as a score, ranging from 1-4, with a higher score indicating greater mask wearing frequency.
|
Baseline
|
|
Mask Wearing Frequency as Assessed by a Survey
Time Frame: 4 weeks post intervention
|
Mask Wearing frequency is reported as a score, ranging from 1-4, with a higher score indicating greater mask wearing frequency.
|
4 weeks post intervention
|
|
Percentage of Participants Who Contacted an Agency About the Gold Card
Time Frame: 4 weeks post intervention
|
Percentage of participants who reported contacting a local community or health agency to request the Gold Card a local medical insurance for low income individuals living in Harris County.
|
4 weeks post intervention
|
|
Percentage of Participants Who Reported Contacting the Agency for Assistance to Get Food
Time Frame: 4 weeks post intervention
|
Percentage of participants who reported seeking food assistance from a local community organization.
|
4 weeks post intervention
|
|
Percentage of Participants Who Reported Contacting the Agency for Assistance With Health Care Resources
Time Frame: 4 weeks post intervention
|
Percentage of participants who reported seeking medical assistance or health advice from a local clinic or community organization.
|
4 weeks post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Maria E Fernandez-Esquer, PhD, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 3, 2023
Primary Completion (Actual)
February 14, 2024
Study Completion (Actual)
February 14, 2024
Study Registration Dates
First Submitted
November 22, 2023
First Submitted That Met QC Criteria
November 22, 2023
First Posted (Actual)
November 24, 2023
Study Record Updates
Last Update Posted (Actual)
April 23, 2025
Last Update Submitted That Met QC Criteria
April 3, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-SPH-20-1389 (phase 2)
- 1R01MD016328-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
Clinical Trials on COVID-19 Group Problem Solving
-
The University of Texas Health Science Center,...National Institute on Minority Health and Health Disparities (NIMHD)Completed
-
The University of Texas Health Science Center,...National Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
Istanbul UniversityCompleted
-
University of OttawaOttawa Hospital Research InstituteActive, not recruiting
-
Washington University School of MedicineNurses for Newborns FoundationCompletedPost-partum DepressionUnited States
-
Rosalind Franklin University of Medicine and ScienceMedical College of Wisconsin; Children's Hospital and Health System Foundation...UnknownInflammatory Bowel DiseaseUnited States
-
VA Office of Research and DevelopmentCompletedDepression | AnxietyUnited States
-
Boston Medical CenterCenters for Disease Control and PreventionCompletedChild AbuseUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedMild Cognitive ImpairmentUnited States